Carol Miceli | Director, Investor Relations |
Jay Luly | President and CEO |
Paul Mellett | SVP, Finance and Administration and CFO |
Brian Abrahams | RBC Capital Markets |
Jessica Fye | J.P. Morgan |
Liisa Bayko | JMP Securities |
Good afternoon. My name is Sarah and I will be your conference operator today. At this time, I would like to welcome everyone to the Enanta Pharmaceuticals First Quarter Financial Results Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session.